Zydus to begin Phase II (a) clinical trial of ZYIL1 in Australia
It is a novel oral NLRP3 inflammasome inhibitor
It is a novel oral NLRP3 inflammasome inhibitor
Results from the ongoing vodobatinib clinical study are being presented for the second consecutive year at the ASH annual meeting, underlining the promising potential of the drug for the treatment of heavily pre-treated CML
Under this scheme, the company will make a committed investment in plant and machinery, get incentives on incremental sales of pharmaceutical products
The company will donate 5000 nebulizers to primary health care centres in rural India
Primary endpoints and secondary endpoints for which data are available were met in trial dominated by Covid-19 variants
The setting up of these 8 plants will lead to a total committed investment of Rs. 260.40 crore
Philips Patient Monitors IntelliVue MX750 and IntelliVue MX850 pair with advanced software and services to offer clinical decision support, continuous, scalable patient management and enhanced infection control
The company plans to expand their capacity to meet the needs of pharma and biotech industries
Approximately five kg tumor was removed in the eight-hour long complicated surgery
Organised by the Indian Stroke Association, it has attracted over 800 doctors from India and overseas
Subscribe To Our Newsletter & Stay Updated